Delivery Order SPE2DB22D3009-SPE2DB25FAY97

Award Date 6/9/25
Potential Completion Date 6/10/25
Potential Value $8.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product. The contract has a ceiling value of $11,996.53 and a completion date of June 6, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corporation holds a substantial Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of SYNVISC-ONE SYRINGE 6ML. The contract has a ceiling value of $7,319.96 and is a firm-fixed price arrangement with an ultimate completion date of September 23, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SYNVISC-ONE SYRINGE 6ML, a specialty pharmaceutical product. The contract has a ceiling value of $11,946.41 and a period of performance ending on February 15, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SYNVISC-ONE SYR 6ML 1S medical supplies, with a ceiling value of $1,295.04 and a performance period ending on June 13, 2025. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a $10,186.98 Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of SYNVISC-ONE SYRINGE 6ML. The delivery order, which has a period of performance through June 10, 2025, is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical. This IDC, designated as SPE2DX, provides a comprehensive global...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SYNVISC-ONE SYRINGE 6ML, a pharmaceutical product. The contract has a ceiling value of $1,280.40 and an ultimate completion date of May 23, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,540.64, is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product. The contract has a firm fixed price and runs until February 25, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,459.76, is for the supply of SYNVISC-ONE SYRINGE 6ML, a specialty medical product, with a period of performance through August 7, 2024. The contract is not designated as a set-aside. In addition to this specific delivery order, AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,562.24 firm-fixed-price delivery order is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product, with a period of performance through March 17, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a $1,273.98 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product, with a period of performance through June 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
  • SPE2DB22D3009
    Indefinite Delivery Contract
  • SPE2DB22D3009-SPE2DB25FAY97
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $8,196.45 and is for the delivery of SYNVISC-ONE SYRINGE 6ML, a medical product, with a period of performance ending on June 10, 2025.

Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including for the Defense Health Agency and U.S. Coast Guard. The contract award does not indicate any set-aside designation, suggesting it was competed on an unrestricted basis.

Generated 9/14/25, 1:08 AM